WiBrain’s Mind Scan Surpasses 360,000 Prescriptions, Revolutionizing Brain Health Diagnostics
Table of Contents
A novel brainwave analysis tool, Mind Scan, developed by WiBrain, has exceeded 360,000 cumulative prescriptions, signaling a significant advancement in the diagnosis of neurological and psychiatric conditions. The device is poised to reshape how clinicians approach conditions often difficult to assess with traditional imaging techniques.
Bridging the Gap in Brain Health Assessment
Traditional diagnostic methods like computed tomography (CT) and magnetic resonance imaging (MRI) excel at identifying structural abnormalities in the brain – tumors, bleeding, and infarction, for example. However, these methods often fall short when it comes to detecting functional issues underlying conditions such as depression, anxiety, ADHD, sleep disorders, and chronic pain. These conditions manifest as disruptions in brain activity, not necessarily visible structural changes.
Mind Scan addresses this critical gap by measuring both brain waves and heart rate variability (HRV). Approved by the Ministry of Food and Drug Safety in 2019, the device analyzes the electrical activity of the brain to visualize and evaluate functional problems, offering a more comprehensive picture of brain health.
P300 Analysis Confirms Diagnostic Accuracy
The efficacy of Mind Scan was recently validated at the EEG Neuropsychological Society for EEG Neurophysiology in August. Researchers demonstrated the device’s ability to accurately capture the P300 graph, a key indicator of the brain’s speed in recognizing and processing stimuli.
The P300 reflects the time it takes for the brain to register a “surprise” or notable stimulus, providing insights into attention, cognitive ability, and overall brain health. According to company data, Mind Scan’s measurement reliability boasts a high score of 0.95.
Expanding Clinical Adoption and Objective Diagnosis
Currently, Mind Scan is utilized in over 310 psychiatric and neurology hospitals across the country. This year alone, more than 10,000 cases have been measured, bringing the total cumulative measurements to over 304,000.
“Mind scans are digitized and statistically analyzed and compared with normal groups to objectively diagnose patients’ diseases by objectively presenting over-performance, low-performance, and abnormal connection patterns,” stated a director of the Department of Mental Health and Medicine. This objective approach represents a significant shift from relying solely on subjective patient reporting and clinical observation.
Lee Ki-won, CEO of WiBrain, hailed the milestone as “a very encouraging achievement as more and more patients are actively treating brain diseases by visiting neurology and psychiatric hospitals.” He expressed confidence that Mind Scan’s objective diagnostic system will prove invaluable in improving patient treatment outcomes.
